Columnist Jennifer Lynne has made her annual in-person visit to her regional hemophilia treatment center, with some adjustments and news.

Altuviiio (efanesoctocog alfa) may work better than other treatments as a hemophilia A factor replacement therapy, a study ...

Columnist Joe MacDonald celebrates the 32nd anniversary of his marriage to Cazandra — and the bond that's helped them deal with hemophilia.

Sharing a personal anecdote, columnist G Shellye Horowitz discusses a potential bleeding risk that develops weeks after a ...

Preventive treatment with Altuviiio led to lower bleed rates and better joint health than Hemlibra in hemophilia A patients ...

Although loved ones have good intentions, columnist Alliah Czarielle corrects some misconceptions about what people with hemophilia need.

No bleeding episodes were seen over three years for 64% of hemophilia A patients given giroctocogene fitelparvovec in a trial ...

With travel scholarships available for the 2025 Coalition for Hemophilia B Symposium, columnist Jennifer Lynne encourages readers to attend.

Columnist Joe MacDonald reflects on moments of joy from one of his oldest son's first Christmases. It was a welcome respite from hemophilia.

The two-part Phase 1/2 trial — dubbed BeCoMe-9 (NCT06611436) — was designed to assess the safety and clinical activity of a ...

To protect her ankles from internal bleeding and pain, columnist G Shellye Horowitz opts for sensible shoes lined with custom ...